Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?
Wills Hughes-Wilson, Ana Palma, Ad Schuurman et al. · Orphanet Journal of Rare Diseases · 2012
Full textCC BY